Cargando…
Update on Immunology of COVID-19 Disease and Potential Strategy for Controlling
Coronavirus disease 2019 (COVID-19) is caused by a novel form of the coronavirus that caused severe acute respiratory syndrome (SARS). SARS-CoV-2 raised in China and has broadcast to 261 countries globally. SARS-CoV-2 a member of β-coronavirus family and has an almost matching genome sequence to a b...
Autores principales: | Dezfuli, Neda K., Adcock, Ian M, Montazami, Nooshin, Mortaz, Esmaeil, Velayati, Aliakbar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088154/ https://www.ncbi.nlm.nih.gov/pubmed/33959165 |
Ejemplares similares
-
Cancers Related to Immunodeficiencies: Update and Perspectives
por: Mortaz, Esmaeil, et al.
Publicado: (2016) -
Immunologic Role of Extracellular Vesicles and Exosomes in the Pathogenesis of Cystic Fibrosis
por: Asef, Alireza, et al.
Publicado: (2018) -
The roles of miRNAs as potential biomarkers in lung diseases
por: Alipoor, Shamila D., et al.
Publicado: (2016) -
Potential diagnostic value of pleural fluid cytokines levels for tuberculous pleural effusion
por: Dalil Roofchayee, Neda, et al.
Publicado: (2021) -
Programmed Cell Death Protein 1 (PD-1) Molecule in Coronavirus Disease 2019 (COVID-19)?
por: Mortaz, Esmaeil, et al.
Publicado: (2021)